Prostate Cancer, Hereditary, 2: Genetic Testing's Role in Risk Assessment and Management
Explore the role of genetic testing in hereditary prostate cancer risk assessment, early detection, personalized treatment plans, and family communication.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Probing Pseudohypoaldosteronism Type 2B: The Role of Genetic Testing
Genetic testing aids in diagnosing Pseudohypoaldosteronism Type 2B, enabling personalized treatment plans and management of this rare genetic disorder effectively.
Probing the Pathways: Genetic Testing in Pseudohypoaldosteronism Type 2C
Explore how genetic testing identifies mutations in Pseudohypoaldosteronism Type 2C to enable personalized treatments, risk assessments, and early interventions.
Pioneering Paths in Pseudohypoaldosteronism Type 2C: The Role of Genetic Testing
Explore how genetic testing is transforming PHA2C diagnosis, management, and family planning with insights into mutations and personalized treatment strategies.
Probing Pseudohypoaldosteronism Type 2D: The Role of Genetic Testing
Explore Pseudohypoaldosteronism type 2D, a rare genetic disorder. Learn how genetic testing offers precise diagnosis, personalized treatment, and family planning insights.
Pioneering Paths in Pseudohypoaldosteronism Type 2E: The Role of Genetic Testing
Explore the impact of genetic testing on diagnosing Pseudohypoaldosteronism Type 2E, uncovering genetic mutations to personalize treatment and guide family planning.
Pioneering Pathways: Genetic Testing for Psychomotor Retardation, Epilepsy, and Craniofacial Dysmorphism
Explore the role of genetic testing in diagnosing Psychomotor Retardation, Epilepsy, and Craniofacial Dysmorphism, aiding early diagnosis and personalized care.
Unraveling the Mysteries of PYCR1-related De Barsy Syndrome Through Genetic Testing
Genetic testing aids the diagnosis and management of PYCR1-related De Barsy Syndrome, enabling early intervention, personalized care, family planning, and research advancement.